Axsome Therapeutics CEO Herriot Tabuteau's 2019 pay jumps 346% to $4.7M
Axsome Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 21, 2020
Axsome Therapeutics reported fiscal year 2019 executive compensation information on April 21, 2020.
In 2019, four executives at Axsome Therapeutics received on average a compensation package of $2.8M, a 281% increase compared to previous year.
Average pay of disclosed executives at Axsome Therapeutics
Herriot Tabuteau, Chief Executive Officer, received $4.7M in total, which increased by 346% compared to 2018. 84% of Tabuteau's compensation, or $4M, was in option awards. Tabuteau also received $326K in non-equity incentive plan and $435K in salary.
For fiscal year 2019, the median employee pay was $166,021 at Axsome Therapeutics. Therefore, the ratio of Herriot Tabuteau's pay to the median employee pay was 28 to one.
David Marek, Chief Commercial Officer, received a compensation package of $3M. 86% of the compensation package, or $2.5M, was in option awards.
Mark Jacobson, M.A, Chief Operating Officer, earned $2M in 2019, a 321% increase compared to previous year.
Nick Pizzie, Chief Financial Officer, received $1.6M in 2019, which increases by 128% compared to 2018.
Related executives
You may also like
Source: SEC filing on April 21, 2020.